The stock of Hims & Hers Health Inc (NYSE:HIMS) last traded at $53.34, down -0.04% from the previous session.
HIMS stock price is now 36.63% away from the 50-day moving average and 77.58% away from the 200-day moving average. The market capitalization of the company currently stands at $11.94B.
With the price target maintained at $30, TD Cowen recently Downgraded its rating from Buy to Hold for Hims & Hers Health Inc (NYSE: HIMS). On February 18, 2025, Morgan Stanley Downgraded its previous ‘Overweight’ rating to ‘Equal-Weight’ on the stock increasing its target price from $42 to quote $60, while ‘Citigroup’ rates the stock as ‘Sell’
In other news, Becklund Irene, PAO sold 5,071 shares of the company’s stock on May 22 ’25. The stock was sold for $271,349 at an average price of $53.51. Upon completion of the transaction, the PAO now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On May 27 ’25, Officer Melissa Baird bought 33,333 shares of the business’s stock. A total of $1,778,649 was incurred on buying the stock at an average price of $53.36. A total of 10.37% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $13.47 and a high of $72.98. As of last week, the company has a debt-to-equity ratio of 0.12, a current ratio of 1.59, and a quick ratio of 1.32.
The net profit margin was 9.21% and return on equity was 36.79% for HIMS. The company reported revenue of $586.01 million for the quarter, compared to $278.17 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 110.67 percent.
